|
Volumn 1, Issue 3, 2016, Pages 366-368
|
Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
WARFARIN;
AGED;
ANTICOAGULATION;
ATRIAL FIBRILLATION;
CEREBROVASCULAR ACCIDENT;
CHARLSON COMORBIDITY INDEX;
COHORT ANALYSIS;
COMORBIDITY;
CONTROLLED STUDY;
DEATH;
FEMALE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
PREVALENCE;
PROPORTIONAL HAZARDS MODEL;
REGRESSION ANALYSIS;
RISK REDUCTION;
CHEMICALLY INDUCED;
COMPLICATION;
MORTALITY;
AGED;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
FEMALE;
HUMANS;
MALE;
STROKE;
WARFARIN;
|
EID: 84991614091
PISSN: 23806583
EISSN: 23806591
Source Type: Journal
DOI: 10.1001/jamacardio.2016.0393 Document Type: Letter |
Times cited : (62)
|
References (6)
|